Acumen Pharmaceuticals, Inc. ($ABOS)
Filing Information
| Accession Number | 0001628280-26-016645 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 11, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
6,270
Total Value
$10,679.90
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Legal Officer & Corp Sec | Common Stock | โ | Mar 6, 2026 | Exercise/Conversion | 2,090 | $1.85 | $3,866.50 | 176,089 | Direct | โ | View Details | |
Chief Legal Officer & Corp Sec | Common Stock | โ | Mar 6, 2026 | Sale | 2,090 | $3.26 | $6,813.40 | 173,999 | Direct | โ | View Details | |
Chief Legal Officer & Corp Sec | Employee Stock Option (right to buy) | Derivative | Mar 6, 2026 | Exercise/Conversion | 2,090 | $0.00 | $0.00 | 71,048 | Direct | โ | View Details |